This suggests that increased expression of TWIST1 plays a role in CTCL progression, and is consistent with the recent discovery that TWIST1 is involved in skin cancer initiation, maintenance and progression in a dose dependent manner [106]. This evidence concerns the gene TWIST1 and skin cancer.